Ebetino; Frank Hallock
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ebetino; Frank Hallock.The latest application filed is for "bone targeted antimicrobial oxazolidinone related compounds, formulations thereof, and uses thereof".
- Ebetino; Frank Hallock - Venice FL
- Ebetino; Frank Hallock - Cincinnati OH
- - Cincinnati OH US
| Patent | Date |
|---|---|
| Skeletal removal of bisphosphonates Grant 11,400,104 - Ebetino , et al. August 2, 2 | 2022-08-02 |
| Bone Targeted Antimicrobial Oxazolidinone Related Compounds, Formulations Thereof, And Uses Thereof App 20210369849 - EBETINO; Frank Hallock ; et al. | 2021-12-02 |
| Skeletal Removal of Bisphosphonates App 20210121485 - Ebetino; Frank Hallock ; et al. | 2021-04-29 |
| Skeletal removal of bisphosphonates Grant 10,857,165 - Ebetino , et al. December 8, 2 | 2020-12-08 |
| Bisphosphonate compounds Grant 8,822,435 - Ebetino , et al. September 2, 2 | 2014-09-02 |
| Bisphosphonate Compounds App 20140194389 - Ebetino; Frank Hallock ; et al. | 2014-07-10 |
| Bisphosphonate compounds Grant 8,710,215 - Ebetino , et al. April 29, 2 | 2014-04-29 |
| Imidazo[1,2-a] pyridinyl bisphosphonates Grant 08618079 - | 2013-12-31 |
| Imidazo[1,2-a] pyridinyl bisphosphonates Grant 8,618,079 - Ebetino , et al. December 31, 2 | 2013-12-31 |
| Bisphosphonate Compounds App 20130035482 - EBETINO; Frank Hallock ; et al. | 2013-02-07 |
| Bisphosphonate compounds Grant 8,314,081 - Ebetino , et al. November 20, 2 | 2012-11-20 |
| 5-azaindole bisphosphonates Grant 8,252,774 - Ebetino , et al. August 28, 2 | 2012-08-28 |
| 5-azaindole Bisphosphonates App 20110237550 - Ebetino; Frank Hallock ; et al. | 2011-09-29 |
| IMIDAZO[1,2-a] PYRIDINYL BISPHOSPHONATES App 20110230443 - Ebetino; Frank Hallock ; et al. | 2011-09-22 |
| Bisphosphonate Compounds App 20110098251 - Ebetino; Frank Hallock ; et al. | 2011-04-28 |
| Composition for treating bone disorders Grant 7,781,418 - Ebetino , et al. August 24, 2 | 2010-08-24 |
| Composition for treating bone disorders App 20090069272 - Ebetino; Frank Hallock ; et al. | 2009-03-12 |
| Melanocortin receptor ligands Grant 7,132,539 - Ebetino , et al. November 7, 2 | 2006-11-07 |
| Melanocortin receptor ligands App 20060247224 - Ebetino; Frank Hallock ; et al. | 2006-11-02 |
| Melanocortin receptor ligands Grant 7,087,759 - Mazur , et al. August 8, 2 | 2006-08-08 |
| Melanocortin receptor ligands App 20060128613 - Ebetino; Frank Hallock ; et al. | 2006-06-15 |
| Melanocortin receptor ligands App 20060106059 - Mazur; Wieslaw Adam ; et al. | 2006-05-18 |
| Melanocortin receptor ligands Grant 7,026,335 - Ebetino , et al. April 11, 2 | 2006-04-11 |
| Melanocortin receptor ligands App 20050239835 - Ebetino, Frank Hallock ; et al. | 2005-10-27 |
| Melanocortin receptor ligands Grant 6,951,916 - Mazur , et al. October 4, 2 | 2005-10-04 |
| Melanocortin receptor ligands App 20050171158 - Ebetino, Frank Hallock ; et al. | 2005-08-04 |
| Melanocortin receptor ligands Grant 6,911,447 - Mazur , et al. June 28, 2 | 2005-06-28 |
| Melanocortin receptor ligands App 20050010031 - Ebetino, Frank Hallock ; et al. | 2005-01-13 |
| Melanocortin receptor ligands App 20040224985 - Mazur, Wieslaw Adam ; et al. | 2004-11-11 |
| Melanocortin receptor ligands App 20040023859 - Mazur, Adam Wieslaw ; et al. | 2004-02-05 |
| Melanocortin receptor ligands App 20040010010 - Ebetino, Frank Hallock ; et al. | 2004-01-15 |
| Melanocortin receptor ligands App 20030236230 - Ebetino, Frank Hallock ; et al. | 2003-12-25 |
| Melanocortin receptor ligands Grant 6,613,874 - Mazur , et al. September 2, 2 | 2003-09-02 |
| Melanocortin receptor ligands App 20030109556 - Mazur, Wieslaw Adam ; et al. | 2003-06-12 |
| 2-decarboxy-2-phosphinico Prostaglandin F analogs Grant 6,372,730 - deLong , et al. April 16, 2 | 2002-04-16 |
| Thio-substituted, Nitrogen-containing, heterocyclic phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism Grant 5,856,314 - Kaas , et al. January 5, 1 | 1999-01-05 |
| Phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism Grant 5,731,299 - Ebetino , et al. March 24, 1 | 1998-03-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 